About the author
Nicole Witowski is a Senior Content Writer at Definitive Healthcare. She brings more than 10 years of experience writing about the healthcare industry. Her work has been cited in Becker’s, Fierce Healthcare, Healthcare Finance News, and more. Prior to joining Definitive Healthcare, she worked as a healthcare analyst at Clarivate and as an intelligence analyst at CB Insights, researching healthcare startups, market trends, and investment activity.
Outside of work, Nicole can usually be found reading fiction or sketching and painting around Chicago.
Recent posts by Nicole
What the CDC’s updated vaccine schedule means for providers, insurers, and drugmakers
Read more
Emerging biopharma launch strategies for commercial success
Read more
Defending your organization against AI-powered phishing attacks
Read more
The coming age of consumer-focused, portable health records
Read more
How to predict healthcare demand in 2026 (and beyond)
Read more
Inside P&T committees: The key players in formulary decision-making
Read more
Why biopharma needs stronger clinical–commercial partnerships
Read more
Unlocking the window for early Alzheimer’s diagnosis
Read more
How drug and device pricing shape insurance underwriting
Read more
Top trends of 2026: Emerging therapies and diagnostics are on track to transform cancer care
Read more
Top trends of 2026: New PBM rules will put market access strategies to the test
Read more
How ACA changes are set to reshape the health insurance landscape
Read more
How pharma is reinventing its growth strategy through M&A
Read more
From PBMs to pricing: How state laws are reshaping the landscape for healthcare players
Read more
Rethinking regulatory strategy in a leaner FDA environment
Read more
3 ways PMSA 2025 showed us the future of pharma analytics
Read more
Managing uncertainty in life sciences as NIH cuts mount
Read more
Agentic AI gets to work behind the desk in healthcare
Read more
From GenAI to health equity: The conversations shaping medical affairs at MAPS 2025
Read more
Is 2025 the big year for pharma M&A — or just more of the same?
Read more
Top health system mergers, acquisitions, and affiliations
Read more
How design in clinical spaces may influence health outcomes
Read more
How MRD testing is improving cancer care and opening new opportunities in oncology
Read more
Mental health finds a new home in urgent care centers
Read more
Capturing medtech opportunities in the growing ASC market
Read more
7 steps to building a winning medtech sales strategy
Read more
Six potential side effects of the Medicare drug price negotiation program
Read more
Pharma’s embrace of real-world data is shaping the future of drug development
Read more
Transforming healthcare with strategic market forecasting
Read more
Elevate your medtech sales strategy with pre-call planning
Read more
How drugmakers can prep for Medicare price talks under the IRA
Read more
Leveraging NPI target lists for strategic advertisement placements in pharmaceutical marketing
Read more
The pivotal role of healthcare IDNs and ACOs in purchasing & population health
Read more
How healthcare mergers and acquisitions affect EHR interoperability
Read more
How to recruit patients for clinical trials in 3 steps
Read more
Unlocking therapeutic frontiers with psychedelic medicine
Read more
What the future holds for hospital mergers and acquisitions
Read more
Are independent physician groups viable in the long run?
Read more
Big retailers are staking their futures on healthcare
Read more
How to leverage technology, reference, and affiliation data in your 2024 sales and marketing strategy
Read more
How healthcare provider organizations are planning for tomorrow
Read more
How healthcare companies can thrive during a downturn
Read more
Unlock new intelligence with the expanded Atlas All-Payor Claims Dataset
Read more